Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KLK5 | Q9Y337 | 3/20 | 0.55 |
| ▸ | BCL2 | P10415 | 3/20 | 0.54 |
| ▸ | REN | P00797 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.52 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.49 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | PSEN1 | P49768 | 3/20 | 0.47 |
| ▸ | PSEN2 | P49810 | 3/20 | 0.47 |
| ▸ | APH1B | Q8WW43 | 3/20 | 0.47 |
| ▸ | NCSTN | Q92542 | 3/20 | 0.47 |
| ▸ | APH1A | Q96BI3 | 3/20 | 0.47 |
| ▸ | PSENEN | Q9NZ42 | 3/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | PPARA | Q07869 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | APP | P05067 | 1/20 | 0.47 |
| ▸ | YAP1 | P46937 | 1/20 | 0.47 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.46 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6158017 | 1.00 | KLK5 (0.55) | KLK5BCL2RENPTPN1ENPP2 | |
| SCHEMBL6158094 | 1.00 | KLK5 (0.55) | KLK5BCL2RENPTPN1ENPP2 | |
| SCHEMBL13537629 | 1.00 | KLK5 (0.55) | KLK5BCL2RENPTPN1ENPP2 | |
| SCHEMBL3984508 | 0.90 | KLK5 (0.65) | KLK5RENPSEN1PSEN2APH1B | |
| SCHEMBL1481008 | 0.90 | KLK5 (0.65) | KLK5RENPSEN1PSEN2APH1B | |
| SCHEMBL638912 | 0.90 | KLK5 (0.65) | KLK5RENPSEN1PSEN2APH1B | |
| SCHEMBL640670 | 0.90 | KLK5 (0.65) | KLK5RENPSEN1PSEN2APH1B | |
| SCHEMBL5171370 | 0.90 | KLK5 (0.65) | KLK5RENPSEN1PSEN2APH1B | |
| SCHEMBL495758 | 0.90 | KLK5 (0.65) | KLK5RENPSEN1PSEN2APH1B | |
| SCHEMBL495756 | 0.90 | KLK5 (0.65) | KLK5RENPSEN1PSEN2APH1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050137408-A1 | Process for producing aminoepoxide | AJINOMOTO CO. INC (JP) | 2005-06-23 | — | — | US | disclosed |
| EP-1505065-A1 | PROCESS FOR PRODUCING AMINOEPOXIDE | Ajinomoto Co., Inc. (JP) | 2005-02-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050137408-A1 | Process for producing aminoepoxide | HAO2, DAO, HAAO | KLK5 4490/4885BCL2 788/4885REN 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.